Foreign investors have injected close to Rs 33,700 crore in domestic equities in this month so far primarily due to interest rate cut in the US and resilience of the Indian market.
This also marks the second highest inflow in a month in this year so far, the last one being in March, when Foreign Portfolio Investors (FPIs) infused Rs 35,100 crore, data with the depositories showed.
Going ahead, the trend of FPIs buying is likely to continue in the coming days, V K Vijayakumar, Chief Investment Strategist, Geojit Financial Services, said.
According to the data with the depositories, Foreign Portfolio Investors put in a net investment of Rs 33,691 crore into equities this month (till September 20).
With this, FPIs investment in equities reached Rs 76,572 crore so far this year. Since June, FPIs have been consistently buying equities. Before that, they pulled out funds to the tune of Rs 34,252 crore in April-May.
In September, FPIs remained bullish, purchasing Indian equities on …
Posts in category Business Standard
FPIs pump Rs 33,700 cr in Indian equities in Sept amid US rate cut (22-09-2024)
Mcap of 6 of top-10 most valued firms jumps Rs 1.9 trn; Infosys tumbles (22-09-2024)
The combined market valuation of 6 of the top-10 most valued firms jumped Rs 1,97,734.77 crore last week, with ICICI Bank and HDFC Bank emerging as the biggest winners, in-line with optimistic trends in equities.
Last week, the BSE benchmark jumped 1,653.37 points or 1.99 per cent.
The BSE benchmark soared 1,359.51 points or 1.63 per cent to settle at an all-time high of 84,544.31 on Friday. During the day, it jumped 1,509.66 points or 1.81 per cent to hit the lifetime intra-day peak of 84,694.46.
The valuation of ICICI Bank surged Rs 63,359.79 crore to Rs 9,44,226.88 crore, the most among the top-10 firms.
HDFC Bank added Rs 58,569.52 crore taking its market valuation to Rs 13,28,605.29 crore.
Bharti Airtel’s valuation soared Rs 44,319.91 crore to Rs 9,74,810.11 crore.
The market capitalisation (mcap) of Reliance Industries climbed Rs 19,384.07 crore to Rs 20,11,544.68 crore.
Hindustan Unilever’s valuation gained Rs 10,725.88 crore to Rs 7,00,084.21 crore and that of ITC went u
Global trends, foreign investors key drivers for markets this week: Experts (22-09-2024)
Investors will keep a track on global trends and trading activity of foreign investors with no major domestic trigger in sight this week, analysts said, and added that markets may face volatility amid the monthly derivatives expiry.
Stock markets had a record-breaking rally last week, largely driven by the US Federal Reserve’s rate cut.
Historically, rate cuts in the US have had a positive impact on emerging markets, with India being a favoured bet among global investors, Santosh Meena, Head of Research, Swastika Investmart Ltd, said.
The highlight of the week was the aggressive buying by Foreign Institutional Investors (FIIs), who poured in over Rs 14,000 crore on Friday alone, he added.
“There are no major triggers expected this week, but upcoming macroeconomic data from the US will be crucial to monitor. FII flows will remain a key factor for the Indian equity market, alongside domestic institutional inflows, which will also play an important role.
“While markets currently seem
Rites allots 24.03 cr equity shares under bonus issue (21-09-2024)
Consequently, the paid-up Equity Share Capital of the Company stands increased to 48,06,03,774 equity shares of Rs 10 each.
Mankind Pharma board OKs to raise Rs 10,000 cr (21-09-2024)
Mankind Pharma said that its board approved to raise funds aggregating to Rs 10,000 crore through non convertible debentures (NCDs) and commercial papers (CPs) on private placement basis.
Glenmark Pharma’s Maharashtra facility clears USFDA inspection (21-09-2024)
Glenmark Pharmaceuticals has announced that its formulation manufacturing facility located in Chhatrapati Sambhaji Nagar (Aurangabad), Maharashtra, has successfully cleared the US Food and Drug Administration (USFDA) inspection with zero observations
BHEL bags order worth over Rs 6,100-cr from NTPC (21-09-2024)
Bharat Heavy Electricals (BHEL) has announced that it has received an order worth over Rs 6,100 crore from NTPC to set up supercritical thermal power project in Chhattisgarh.
Aarti Drugs’ Maharashtra facility gets 7 observations from USFDA (21-09-2024)
Aarti Drugs announced that the United States Food and Drug Administration (USFDA) conducted an inspection at its active pharmaceutical ingredient (API) manufacturing facility located in MIDC, Tarapur, Maharashtra.
ONGC Videsh signs new gas deal for ACG Field, Azerbaijan (21-09-2024)
ONGC Videsh acquired 2.31% participating interest in ACG project in 2013
Glenmark Pharma successful concludes USFDA inspection of its Aurangabad unit (21-09-2024)
Powered by Capital Market – Live News